Salute e Benessere
Orexo Q2 2024 Interim Report
Q2 2024 highlights
Important events after the end of the period
For the full CEO comments view attached PDF.
Contact persons quarterly report:
Nikolaj Sørensen, President and CEO
Fredrik Järrsten, EVP and CFO
Lena Wange, IR & Communications Director
Tel: +46 18 780 88 00, +1 855 982 7658,
E-mail: ir@orexo.com .
Presentation:
On July 17 , at 2 pm CET analysts, investors and media are invited to attend a presentation, incl. a Q&A.
To attend via teleconference where you can ask questions verbally:
https://conference.financialhearings.com/teleconference/?id=50048737
When registered you will be provided phone numbers and a conference ID to access the conference.
To attend via webcast:
https://ir.financialhearings.com/orexo-q2-report-2024/register
Prior to the call, presentation material will be available on the website under Investors/Reports/Audiocasts.
This information is information that Orexo AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact persons set out above at 8 am CET on July 17, 2024 .
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/orexo/r/orexo-q2-2024-interim-report,c4015814
The following files are available for download:
View original content: https://www.prnewswire.co.uk/news-releases/orexo-q2-2024-interim-report-302199082.html